Entac Medical Inc.

Entac Medical Inc.

location_on Sureste ,  Estados Unidos

Por favor toma nota:
Invirtiendo en empresas jóvenes lleva riesgos como falta de liquidez, falta de dividendos, pérdida de inversión y dilución. Debería hacer parte de un portafolio diversificado. La plataforma está dirigida únicamente a inversores sofisticados que entienden estos riesgos y pueden hacer sus propios decisiones cuando están invirtiendo. Esta información no ha sido aprobada como una promoción financiera y Ud. tiene que hacer su propia diligencia debida.

Resumen corto

Entac develops AI-driven acoustic wearables predicting patient adverse events, with its first launched device, PrevisEA, targeting an $8 billion market and a pipeline for multiple high-value healthcare sectors exceeding $20 billion.

Puntos claves

  • PrevisEA Commitments: 5 hospitals systems (63 hospitals) $41M revenue oppy
  • In review: 6 systems (71 hospitals) - $39M opportunity. Commitment due
  • Engaged: 7 systems (120 hospitals) - $67M opportunity - Expected in 2025.
  • Interest: 27 systems (328 hospitals)-$119M opportunity. Expected 2025-26.
  • 80 systems (~1000 hospitals) engaged with PrevisEA at all sales stages

Resumen

Objetivo €1,700,000
Mínimo €45,000
Inversión recaudada €700,000
Rondas anteriores €6,800,000
Fase Vendiendo
Función del inversor Any

Haga una pregunta
¿Tiene alguna pregunta?

Propuestas Similares

Enertor Insoles

Enertor Insoles

location_onEast Anglia, Reino Unido

Transform sports recovery & performance with Enertor's PX1® insoles—revolutionary technology reducing impact by 51%. Endorsed by Usain Bolt, we aim to be the next £1B brand. Invest in innovation redefining running and injury prevention. Raised £330K✅

  • 69% injury reduction proven in clinical trials with British Army
  • Endorsed by Usain Bolt; trusted by elite athletes worldwide
  • Rated best insoles by The New York Times and Runner's World

350.000 €

Total requerido

6000 €

Mínimo por inversor
Ostoform

Ostoform

location_onMidlands, Irlanda

Ostoform enables ostomy patients to live a life free from the worry of leaks and skin complications.

  • Product range developed and ready for commercial scale-up.
  • Distribution deals in place across 8 markets.
  • Reliable, recurring revenue streams in place.

2.000.000 €

Total requerido

15.000 €

Mínimo por inversor
Kaya AI Healthtech

Kaya AI Healthtech

location_onHolanda Septentrional, Países Bajos

Our AI removes clinician burdens so that patients can receive better personalised healthcare. We deliver faster, more accurate diagnosis and treatment planning, reducing delays and improving quality of life.

  • Specialist AI models cut diagnosis time from 15 mins to 5 seconds.
  • €3B SAM in EU dermatology & nutrition with clear expansion path.
  • CE mark path underway with pilots at leading Dutch hospitals.

1.500.000 €

Total requerido

100.000 €

Mínimo por inversor
Loading…
Loading the web debug toolbar…
Attempt #